Record overview
Status and phase
Status: COMPLETED
Phase: PHASE1, PHASE2
Sponsor: Celyad Oncology SA
Condition: AML, MDS
NCT03466320
DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.